Special Issue "Personalized Medicine in Blood Disease of Children"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: closed (5 September 2022) | Viewed by 13537
Special Issue Editors

Interests: clinical and laboratory haematology

Interests: hemoglobinopathies; genetic modifiers; patient registries; biological databases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue of the Journal of Personalized Medicine aims to highlight the current state of the research and current practice on personalized medicines in children's blood non-malignant disorders, such as haemoglobinopathies and bleeding disorders. It aims to collect, share, and expand knowledge on the genetic and molecular basis of phenotypic variation in these disorders, and on the use of omics and digital science, leading to the identification of possibly successful candidate diagnostic and therapeutic approaches. Moreover, the Special Issue will explore the complexity of conducting personalized medicine clinical studies in children affected by rare haematological diseases, including patient registry standardization, ethics, feasibility, cost, and patient engagement and roles. Papers may also address the use of digital tools and advanced therapy medicinal products (ATMPs) for preliminary results. Original articles and reviews are welcome.
Prof. Dr. Adriana Ceci
Dr. Petros Kountouris
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Child blood non-malignant diseases
- Molecular target and disease models
- Genetic variation and diagnosis
- Genotype–phenotype correlation and patient stratification
- Advanced therapy medicinal products
- Biomarkers targeting paediatric blood diseases
- Computational approaches in personalized medicine
- Patient registries and standardization
- Ethics issues and patients-oriented perspectives